Pure Global

Zika Virus IgG/IgM Antibody Rapid Test - India CDSCO Medical Device Registration

Zika Virus IgG/IgM Antibody Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000113_c77983ea276a261d4a60ce63ed482064_3b4fdf1611a0abc91f9979a2e24c3592. This device is marketed under the brand name Chimera. The license holder is CHIMERA BIOTECH PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is South Delhi Division.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Zika Virus IgG/IgM Antibody Rapid Test
UID: MFG/IVD/2023/000113_c77983ea276a261d4a60ce63ed482064_3b4fdf1611a0abc91f9979a2e24c3592

Brand Name

Chimera

Device Class

Class B

Approving Authority

South Delhi Division

Product Information

Zika Virus IgG/IgM is a rapid immunochromatographic assay for the simultaneous detection of IgG and IgM antibodies to Zika virus in human whole blood, serum or plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing